期刊文献+

C1酯酶抑制剂的非蛋白酶抑制功能

Biological activities of C1 inhibitor independent of protease inhibition
原文传递
导出
摘要 C1酯酶抑制剂(C1 esterase inhibitor,C1INH)属于丝氨酸蛋白酶抑制剂家族,能够调节补体系统、激肽释放系统、纤溶系统和凝血系统。目前在临床上主要用于遗传性血管性水肿的治疗。但最近的研究表明C1INH除丝氨酸蛋白酶抑制作用外,还具有多种非蛋白酶抑制功能,如抗炎和抗凋亡作用。而且很多动物实验和临床试验显示C1INH对脓毒症(sepsis)、心肌缺血等疾病也有治疗作用。本文主要综述C1INH的非蛋白酶抑制功能的最新研究进展。 C1 esterase inhibitor belongs to the superfamily of serine proteinase inhibitors (serpins) and regulates several important systems including the complement system, the contact activation system, the fibrinolytic system, and the intrinsic pathway of coagulation. It is currently used for the treatment of hereditary angioedema in clinic. However, recent studies have suggested that C 1 esterase inhibitor may have potential use in the treatment of diseases other than hereditary angioedema, such as sepsis and reperfusion of ischemic myocardium, due to its new biological activities, for instance, anti-inflammation and anti-apoptosis, unrelated to protease inhibition. Here we review the biological activities of C1 inhibitor independent of protease inhibition.
出处 《生命的化学》 CAS CSCD 2012年第4期328-331,共4页 Chemistry of Life
关键词 C1酯酶抑制剂 生物学功能 抗炎 脓毒症 C 1 inhibitor biological activities anti-inflammation sepsis
  • 相关文献

参考文献23

  • 1Caliezi C et al. Cl-esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharmacol Rev, 2001, 52:91-112.
  • 2Joseph K et al. Factor XIl-independent cleavage of high- molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor. J Allergy Clin Immunol, 2009, 2:143-149.
  • 3Rossi Vet al. Functional characterization of the recombinant human C1 inhibitor serpin domain: insights into heparin binding. J Immunol, 2010, 184:4982-4989.
  • 4Cai Set al. Complement regulatory protein C1 inhibitor binds to selectins and interferes with endothelial-leukocyte adhesion. J Immunol, 2003, 171:4786-4791.
  • 5Bock CS et al. Human CI inhibitor: primary structure, cDNA cloning, and chromosomal localization. Biochemistry, 1986, 25: 4292 -4301.
  • 6Beinrohr Let al. C1 inhibitor serpin domain structure reveals the likely mechanism of heparin potentiation and conformational disease. J Biol Chem, 2007, 282:21100-22110.
  • 7Nidden HM et al. Cl-esterase inhibitor blocks T lymphocyte proliferation and cytotoxic T lymphocyte generation in vitro. Int lmmunol, 1998, 10:167-173.
  • 8Thorgersen EB et al. Anti-inflammatory effects of C l-inhibitor in porcine and human whole blood are independent of its protease inhibition activity. Innate Immun, 2010, 16:254-264.
  • 9Dorresteijn MJ et al. C l-esterase inhibitor attenuates the inflammatory response during human endotoxemia. Crit Care Med, 2010, 38:2139-2145.
  • 10Storini C et al. C J-inhibitor protects against brain ischemia- reperfusion injury via inhibition of cell recruitment and inflammation.NeurobiolDis, 2005, 19:10-17.

二级参考文献7

  • 1张沛,杨跃进,宋来凤,阮英茆,周燕文,田毅,陈纪林,陈在嘉,徐义枢.小剂量依那普利对大鼠急性心肌梗死左室重构和功能的影响[J].中华老年心脑血管病杂志,2000,2(6):408-411. 被引量:11
  • 2邱振宇,周盾.细胞间黏附分子-1与肾缺血再灌注损伤[J].基础医学与临床,2007,27(1):100-104. 被引量:4
  • 3Shagdarsuren E, Bidzhekov K, Djalali Talab Y, et al. C1 -esterase inhibitor protects against neointima formation after arteria injury in atherosclerosis-prone mice. Circulation, 2008,117 : 70- 78.
  • 4Tanhehco EJ,Kilgore KB, Naylor KB, et al. Reduction of myo cardial infarct size after ischemia and reperfusion by the glyco saminoglycan polysulfate. Science, 1999,34 : 153-161.
  • 5Souzar-Moraes MR, David Filho R, Baptista Silva JC, et al. Effect of antibodies to intercellular adhesion molecule type 1 on the protection of distant organs during reperfusion syndrome in rats. Braz J Med Biol Res,2009,36:605- 612.
  • 6Brook E, Herbert AP,Jenkins HT,et al. Opportunities for new therapies based on the natural regulators of complement activation. Ann N Y Acad Sci,2005,1056:176-188.
  • 7Horstick G, Berg O, Herbert A, et al. Application of Cl-esterase inhibitor during reperfusion of ischemie myocardium: doserelated beneficial versus detrimental effects. Circulation, 2010, 104:3125-3131.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部